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Aims: Exposure to particulate air pollution is associated with increased blood pressure (BP), a well-es-
tablished risk factor for cardiovascular disease. To elucidate the mechanisms underlying this relationship,
we investigated whether the effects of particulate matter of less than 10 μm in aerodynamic diameter
(PM10) on BP are mediated by microRNAs.
Methods and results: We recruited 90 obese individuals and we assessed their PM10 exposure 24 and 48 h
before the recruitment day. We performed multivariate linear regression models to investigate the ef-
fects of PM10 on BP. Using the TaqMan
s Low-Density Array, we experimentally evaluated and technically
validated the expression levels of 377 human miRNAs in peripheral blood. We developed a mediated
moderation analysis to estimate the proportion of PM10 effects on BP that was mediated by miRNA
expression.
PM10 exposure 24 and 48 h before the recruitment day was associated with increased systolic BP
(β¼1.22 mmHg, P¼0.019; β¼1.24 mmHg, P¼0.019, respectively) and diastolic BP (β¼0.67 mmHg,
P¼0.044; β¼0.91 mmHg, P¼0.007, respectively). We identiﬁed nine miRNAs associated with PM10 levels
48 h after exposure. A conditional indirect effect (CIE¼0.1431) of PM10 on diastolic BP, which was
mediated by microRNA-101, was found in individuals with lower values of mean body mass index.
Conclusions: Our data provide evidence that miRNAs are a molecular mechanism underlying the BP-
related effects of air pollution exposure, and indicate miR-101 as epigenetic mechanism to be further
investigated.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
According to the World Health Organization (WHO), the effects
of exposure to ambient air pollution result in approximately
7 million premature deaths worldwide each year, representing one
out of every eight deaths from any cause. In 2010, there were anInc. This is an open access article u
od pressure; PM, Particulate
diameter; miRNAs, Micro-
ex; CIE, Conditional indirect
DA, TaqMan Low-Density
way Analysis
a),
it (L. Dioni),
mi.it (C. Battaglia),
liclinico.mi.it (L. Vigna),
lati@unimi.it (V. Bollati).estimated 600,000 premature deaths in Europe, including 32,447
deaths in Italy (WHO Regional Ofﬁce for Europe, 2015).
Previous studies of the public health relevance of exposure to
air pollution have shown that this factor is one of the main triggers
of cardiovascular disease (CVD), with incidence and risk rates in
CVD similar to those of alcohol consumption and cocaine abuse
(Nawrot et al., 2011). Elevated blood pressure (BP) is a well-es-
tablished risk factor for CVD. An increase in systolic BP of 1 mmHg
has been estimated to raise the risk of CVD death by 2–4% (Stamler
et al., 1993; Van den Hoogen et al., 2000). Data from epidemio-
logical and controlled human studies have shown that exposure to
particulate matter (PM), a major air pollutant made of small par-
ticles emitted from motor vehicles and industries (Urch et al.,
2005; Brook and Rajagopalan 2009, Brook et al., 2009; Dvonch
et al., 2009), increases BP after exposure times ranging from 2 h to
8 days. Although several studies have demonstrated the harmful
effects of air pollution exposure on cardiovascular outcomesnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Graphical representation of mean PM10 concentration levels and the distribution of participants’ residences. Mean PM10 concentrations in the Lombardia region (Italy)
were predicted by the FARM model in each 44 km2 grid during the study period, from September 1, 2010 to January 28, 2011.
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2009), the intermediate mechanisms by which these effects occur
remain largely unexplored.
Blood microRNAs (miRNAs) have been suggested to be an ac-
tive component of the cellular response to PM exposure. MiRNAs
are single-stranded short noncoding RNA sequences of 22 nu-
cleotides that regulate gene expression at the posttranscriptional
level. Altered miRNA expression is an established mechanism by
which chemical agents induce alterations in target cells. Protective
mechanisms such as the p53-related activation of DNA-repair
processes, cell-cycle arrest, and apoptosis have been suggested to
be activate by miRNAs belonging to the let-7 and miR-34 families
(Izzotti and Pulliero, 2014). It has been shown experimentally that
PM triggers local pulmonary inﬂammation and oxidative stress,
leading to the release of pro-inﬂammatory signals, such as cyto-
kines (Nemmar et al., 2001), and alterations of miRNA levels in theblood. Moreover, numerous miRNAs are known to be expressed in
the cardiovascular system, supporting the possibility that most
physiological and pathological events in the cardiovascular system
are controlled, at least in part, by miRNAs (Hata, 2013). Due to
their easy withdrawal accessibility, circulating blood miRNAs have
been investigated as potential biomarkers of CVDs, such as hy-
pertension (Dickinson et al., 2013), heart failure (Tijsen et al.,
2010), acute myocardial infarction (MI) (Wang et al., 2014), cor-
onary artery disease (Ren et al., 2013), and stroke (Li et al., 2014).
Obesity, deﬁned as a body mass index (BMI) of 30 kg/m2 or
greater, is a strong risk factor for CVD. Obesity has been demon-
strated to modify the effects of PM exposure on heart rate varia-
bility and markers of inﬂammation, oxidative stress, and acute
phase response (Schwartz et al., 2005; Dubowsky et al., 2006;
Schneider et al., 2008). These effects could be due, at least in part,
to an higher PM dose rate in obese individuals, as has been
V. Motta et al. / Environmental Research 146 (2016) 274–281276demonstrated in children by Bennett and Zeman (2004). These
ﬁndings suggest that obese individuals might represent a suitable
population in which to investigate PM-mediated cardiovascular
effects and related pathogenic mechanisms.
To the best of our knowledge, few studies have documented
changes in BP levels after PM10 exposure, and no study has in-
vestigated the possible role of miRNAs as mediators of this asso-
ciation. In the present study, we investigated the effects of ex-
posure to PM of less than 10 μm in aerodynamic diameter (PM10)
on cardiovascular outcomes, such as systolic and diastolic BP, in
overweight and obese participants living in Lombardia, Italy. We
experimentally evaluated the expression levels of 377 human
miRNAs in the peripheral blood of participants and analyzed the
effects of PM10 exposure on miRNA patterns. Furthermore, we
performed a mediated moderation analysis to estimate the pro-
portion of PM10 effects on BP that are mediated by miRNA ex-
pression. Findings from this study have the potential to enhance
current understanding of the molecular mechanisms that drive the
effects of air pollution exposure on BP.2. Material and methods
2.1. Study population
Ninety overweight and obese subjects were recruited at the
Center for Obesity and Work (Fondazione IRCCS Cà Granda Ospe-
dale Maggiore Policlinico in Milan, Lombardia, Italy) from Septem-
ber 2010 to January 2011 as part of the cross-sectional SPHERE
study (Bollati et al., 2014). Each participant provided written in-
formed consent before inclusion in the study, which was approved
by the Ethics Committee of Fondazione IRCCS Cà Granda Ospedale
Maggiore Policlinico (approval number 1425). The investigation is
conforming to the principles outlined in the Declaration of Helsinki.
As part of the routine protocol, each subject presenting at the
Center underwent physical and anthropometric examinations on
the day of recruitment. These examinations included measure-
ments of weight, height, and BP (measured with the participant
supine, after 5 min of rest). Each subject provided a 7-ml blood
sample for analyses of miRNA expression (see Supplemental ﬁle:
Blood collection and RNA isolation).
2.2. Assessment of PM exposure
Daily PM10 concentrations were measured at each participant's
residential address from September 1, 2010 to January 28, 2011.
PM10 levels were estimated with the Flexible Air Quality Regional
Model (FARM), a three-dimensional Eulerian 44 km2 grid model
that considers the dispersion, transformation, and deposition of
particulates. According to this model, the Lombardia Region was
divided into 1678 cells, each associated with an estimated PM10
level. To assign a PM10 exposure level to each subject, the re-
sidential addresses were georeferenced, and the resulting map
was superimposed on the FARM grid (Fig. 1).
2.3. Proﬁling and validation of miRNA expression
MiRNA expression was proﬁled with the TaqMans Low-Density
Array (TLDA) (TaqMans Array Human MicroRNA A Cards Set v2.1;
Life Technologies, Carlsbad, CA). Each TLDA card detects 384 fea-
tures, including 377 human miRNAs, three endogenous small RNA
controls (RNU6, RNU44, and RNU48, the ﬁrst in quadruplicate),
and a negative control (Ath-miR159a). All reactions were per-
formed as speciﬁed in the manufacturer's protocols. Brieﬂy, after
reverse transcription (RT) (see Supplemental ﬁle: RNA reverse
transcription for miRNA expression proﬁling), a total reactionmixture containing RT products and the TaqMan Universal PCR
Master Mix (Life Technologies) was added to each line of TLDA
after gentle vortexing. Each card was centrifuged and mechanically
sealed with a Life Technologies sealer device. TLDAs were run in a
7900HT Fast Real-Time PCR System (Life Technologies) under the
following thermal cycler conditions: 50 °C for 2 min, 94.5 °C for
10 min, 40 cycles of 97 °C for 30 s, and 59.7 °C for 1 min. Twenty-
eight candidate miRNAs were validated with a custom TLDA, on
which the TaqMans miRNA assays were preplated in triplicate
(see Supplemental ﬁle: RNA RT for miRNA expression validation).
The coefﬁcient of variation for the triplicates was 0.62%. After RT,
all reactions were performed as described above.
2.4. Analysis of miRNA expression
Real-time PCR quantiﬁes miRNA expression in terms of cycle
threshold (Ct). We applied restrictive miRNA selection criteria.
Values that were missing, had a Ct greater than 33, or had an
ampscore less than 1 were set equal to the detection limit (35 Ct).
To reduce background noise, we excluded miRNAs with at least
90% of samples not expressed (Ct¼35), producing a ﬁnal dataset of
122 miRNAs. For each miRNA, the expression level was normalized
to the average Ct of three endogenous controls (RNU6, RNU44, and
RNU48). The fold change relative to the calibrator (pool of all 90
samples) was calculated for expression data analysis.
2.5. Statistical analysis
Descriptive statistical data were obtained for the demographic,
physical, and anthropometric variables. The mean and standard
deviation (7SD) were calculated for normally distributed data.
Associations between the daily PM10 concentrations 24 and 48 h
before the recruitment day and cardiovascular parameters, such as
systolic and diastolic BP, were assessed. We performed multivariate
linear regression analyses adjusting for age, sex, BMI, and smoking
habits. The interaction term between BMI and PM10 exposure
(BMI PM10) was tested and included in the models because it was
statistically signiﬁcant (Po0.05). We used linear regression models
to verify the association between PM10 exposure and miRNA ex-
pression in the screening and validation phases. MiRNA expression
values were log2-transformed to achieve a normal distribution.
Multivariate regression analyses adjusted for age, sex, BMI, smoking
habits (current smoker, non-smoker, or ex-smoker), % of granulo-
cytes, recruitment date, and ambient apparent temperature were
applied to evaluate changes in miRNA expression in association
with daily PM10 concentrations.
Due to the high number of comparisons, we applied a multiple
comparison correction based on the False Discovery Rate (FDR)
control. A threshold of 0.10 was applied to the FDR P-value sig-
niﬁcance level to identify the set of top miRNAs. The same analyses
were repeated in the validation phase on the set of 28 candidate
miRNAs selected for technical validation. All statistical analyses
were performed with SAS software, version 9.3.
2.6. Mediated moderation analysis
We performed mediated moderation analysis to estimate the
effect of the interaction between PM10 exposure and BMI on BP,
mediated by miRNA. We considered PM10 as the independent
variable, miRNAs as possible mediators, BMI as a moderator, and
systolic and diastolic BP as dependent variables. All variables ex-
cept BP were centered before being entered into the regression
models (Fig. 2 – Conceptual diagram).
Linear regression coefﬁcients were estimated by three equa-
tions (Fig. 2 – Statistical diagram) (Muller et al., 2005):
Fig. 2. Mediated moderation analysis. In the conceptual diagram, PM10 is the independent variable, miR-101 is the possible mediator, BMI is the moderator, and BP is the
dependent variable. The statistical diagram shows the estimated linear regression coefﬁcients.
Table 1
Characteristics of study participants (n¼90).
Characteristics
Age, years 51.6711.9
Sex
Male 15 (16.7%)
Female 75 (83.3%)
BMI*, kg/m2 32.975.7
Overweight (25rBMIo30) 34 (37.8%)
Class I obesity (30rBMIo35) 28 (31.1%)
Class II obesity (35rBMIo40) 19 (21.1%)
Class III obesity (BMIZ40) 9 (10.0%)
Waist Circumference, cm 103.11712.5
Smoking habits
Never smoker 48 (53.3%)
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the total exposure effect (β )13 when a moderation effect occurs
between PM10 and BP;
 β β β ϵ=β + + + +miRNA PM10 BMI PM10BMI20 21 22 23 2, which es-
timates part of the indirect exposure effect (i.e., whether mod-
eration occurs between PM10 and miRNAs);
 β β β β β=β + + + + +BP PM10 BMI PM10BMI miRNA miRNA30 31 32 33 34 35
ϵ+BMI 3, which estimates part of the indirect exposure effect
(i.e., whether moderation occurs between miRNAs and BP, when
the PM10 effect is controlled) and the direct exposure effect β( )33
(i.e., whether moderation occurs between PM10 and BP, when
the miRNAs are controlled).
MiRNA expression was log2-transformed to achieve a normal
distribution. All linear regression models were adjusted for age,
sex, and smoking habits.
To apply mediated moderation models, there must not be a
correlation between the independent variable (PM10) and the
moderator (BMI). In addition, three criteria must be satisﬁed. First,
there must be a statistically signiﬁcant moderation effect between
the exposure and outcome. In other words, the magnitude of the
overall PM10 exposure effect on BPmust depend on the value of BMI.
Second, either 1) there must be a moderation effect between PM10
exposure and miRNAs, and the miRNAs must have an effect on BP
when PM10 exposure is controlled; and/or 2) there must be a
moderation effect betweenmiRNAs and BP, and PM10 exposure must
have an effect on miRNAs. Third, moderation of the direct effect
must be reduced in magnitude (or even nonsigniﬁcant) compared to
moderation of the total effect. Only if all three criteria are satisﬁed
we can evaluate the conditional direct and indirect effects. The
conditional indirect effect (CIE) estimates the effect size of PM10
exposure on BP that is mediated by miRNAs at different BMI levels.
Mediated moderation analyses were executed on the SAS ver-
sion 9.3 macro, while utilizing the PROCESS program (model 59)
provided by Hayes (2013). Bootstrap conﬁdence intervals (CIs) were
provided with the number of bootstrap samples equal to 10,000.Ex-smoker 26 (28.9%)
Current smoker 16 (17.8%)
Systolic blood pressure, mmHg 124.8716.5
Diastolic blood pressure, mmHg 79.271.2
Apparent temperature, °C 8.777.4
Granulocyte, % 61.377.6
* BMI: Body Mass Index. Continuous variable are
expressed as mean7standard deviation (SD). Dis-
crete variables are expressed as counts (%).3. Results
3.1. Characteristics and exposure of study participants
This study included 90 overweight and obese participants
(16.7% men, 83.3% women), who had a mean age of 51.6 years. BMIwas calculated as the weight divided by the height squared (kg/
m2). Participants were classiﬁed by BMI as overweight, class I
obese, class II obese and class III obese, or severe obese. Mean BMI
for 90 subjects was 32.975.7 Kg/cm2 and mean waist cir-
cumference was 103.11712.5 cm. The mean systolic and diastolic
BP values were 124.8 and 79.2 mmHg, respectively (Table 1).
Under the hypothesis that the variation in miRNA expression
level is a short-term mechanism (Ruegger and Grosshans, 2012),
we chose to investigate a 1-week lag exposure time window be-
fore the recruitment day. We estimated the daily mean PM10 ex-
posure levels at each participant's residential address for the
7 days before recruitment (see Supplemental ﬁle: Supplemental
Table 1). Most participants (60.9%) were enrolled during the
winter season, and most lived in Milan (84.9%).
3.2. Inﬂuence of PM10 exposure on BP
We studied the association of ambient PM10 lag exposure each
of the seven days before the recruitment day with cardiovascular
risk factors, such as systolic and diastolic BP. Only mean levels of
ambient PM10 at 24 and 48 h before recruitment resulted to be
Table 2
Association of PM10 lag exposure with systolic and diastolic BP levels.
β SE 95%CI P-value
Systolic BP 24 h PM10 1.22 0.51 0.20;2.24 0.019
BMI 1.40 0.55 0.31;2.49 0.013
24 h PM10*BMI 0.04 0.02 0.07;-0.01 0.012
Diastolic BP 24 h PM10 0.67 0.33 0.02;1.32 0.044
BMI 0.74 0.35 0.04;1.44 0.037
24 h PM10*BMI 0.02 0.01 0.04;-0.003 0.021
Systolic BP 48 h PM10 1.24 0.52 0.21;2.27 0.019
BMI 1.67 0.67 0.35;3.00 0.014
48 h PM10*BMI 0.04 0.02 0.07;0.008 0.015
Diastolic BP 48 h PM10 0.91 0.33 0.25;1.56 0.007
BMI 1.10 0.42 0.26;1.94 0.011
48 h PM10*BMI 0.03 0.01 0.05;0.01 0.006
Table 3
List of 28 miRNAs selected for validation in association with PM10 lag exposure of
48 h.
MicroRNA PM10 lag exposure (h) Δ% Δ% 95%CI P FDR* P
miR-145 48 0.95 1.50;0.40 0.001 0.025
miR-197 48 -0.66 1.15;0.18 0.008 0.062
miR-30b 48 0.83 1.43;0.22 0.009 0.062
miR-345 48 0.95 1.65;0.25 0.009 0.062
miR-26a 48 1.48 2.61;0.33 0.012 0.069
miR-425-5p 48 0.61 1.11;0.11 0.017 0.080
miR-331 48 0.79 1.46;0.12 0.022 0.080
miR-140-3p 48 0.82 1.52;0.12 0.023 0.080
miR-101 48 1.14 2.15;0.13 0.028 0.088
miR-339-5p 48 0.79 1.54;0.04 0.040 0.110
miR-574-3p 48 0.57 1.12;0.02 0.043 0.110
miR-451 48 0.81 1.60;0.01 0.048 0.112
miR-320 48 0.47 0.97;0.03 0.063 0.136
miR-532-3p 48 0.54 1.14;0.07 0.080 0.151
miR-301 48 1.81 3.83;0.26 0.086 0.151
miR-16 48 1.03 2.20;0.16 0.089 0.151
miR-24 48 0.60 1.30;0.10 0.092 0.151
miR-125a-5p 48 0.54 1.19;0.11 0.102 0.159
miR-222 48 0.67 1.51;0.17 0.117 0.168
miR-183 48 1.45 3.26;0.39 0.120 0.168
miR-182 48 0.91 2.13;0.31 0.141 0.188
miR-99b 48 1.12 2.72;0.52 0.176 0.218
miR-21 48 0.80 1.98;0.40 0.188 0.218
miR-362-3p 48 1.20 2.98;0.62 0.193 0.218
miR-15b 48 0.79 1.97;0.41 0.194 0.218
miR-486-3p 48 0.72 2.64;1.24 0.467 0.502
miR-150 48 0.13 0.53;0.27 0.527 0.547
miR-296 48 0.21 1.30;0.90 0.711 0.711
Δ% estimates the percentage change in miRNA expression for a 1-μg/m3 increase in
PM10 exposure level. Associations with FDR Po0.10 are shown in bold.
* FDR: False Discovery Rate
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vels. An increase in ambient PM10 of 1 μg/m3 at 24 h before the
recruitment was associated with an mean increase in systolic BP of
1.22 mmHg (SE¼0.51; P¼0.019) and an mean increase in diastolic
BP of 0.67 mmHg (SE¼0.33; P¼0.044) (Table 2). An increase in
ambient PM10 of 1 μg/m3 at 48 h before the recruitment was as-
sociated with an average increase in systolic BP of 1.24 mmHg
(SE¼0.52; P¼0.019) and an average increase in diastolic BP of
0.91 mmHg (SE¼0.33; P¼0.007) (Table 2). Signiﬁcant interaction
terms between BMI and PM10 exposure 48 h before recruitment
(48 h PM10*BMI ) were obtained for systolic BP (P¼0.015) and
diastolic BP (P¼0.006). The regression model results supported
the hypothesis that BMI moderates the effect of PM10 exposure on
systolic and diastolic BP.
3.3. Inﬂuence of PM10 exposure on miRNA expression levels
To determine whether there is a speciﬁc miRNA signature as-
sociated with exposure to ambient PM10, we used TLDA to screen
for miRNAs whose expression levels are correlated with the daily
mean PM10 values. We chose to investigate PM10 lag exposure
levels 24 and 48 h before the recruitment day since they were
signiﬁcantly associated with elevated systolic and diastolic BP le-
vels. After data cleaning (see Section 2.4), we obtained 122 miR-
NAs. We investigated their association with PM10 exposure values
using multivariate analysis. Using a Benjamini–Hochberg FDR ad-
justment for multiple comparisons (FDR Po0.1), we found 19
miRNAs that were signiﬁcantly associated with the PM10 exposure
level 48 h before recruitment. A negative association was observed
for all miRNAs (see Supplemental ﬁle: Supplemental Table 2),
suggesting a suppressive effect of PM10 exposure on the miRNA
expression levels.
3.4. Validation of candidate miRNAs with PM10 exposure levels
We used a custom RT-qPCR assay to conﬁrm the expression
levels of candidate miRNAs that we identiﬁed in the screening
analysis. To avoid the exclusion of some relevant miRNAs involved
in PM10 exposure and BP regulation, 28 candidate miRNAs were
chosen for validation, on the basis of their signiﬁcant FDR P-values
and their roles in BP regulation, CVD, and air pollution exposure
(Pan et al., 2012; Deng et al., 2014; Neppl and Wang, 2014; Cakmak
et al., 2015; Cengiz et al., 2015) (see Supplemental ﬁle: Supple-
mental Table 3).
Nineteen of the 28 candidate miRNAs resulted not to be sig-
niﬁcantly associated with PM10 exposure. Nine miRNAs were ne-
gatively associated with PM10 lag exposure levels 48 h before the
recruitment day (FDR Po0.1; Table 3). Every 1-mg/m3 increase in
PM10 exposure levels was associated with a 1.48% decrease in miR-
26a expression (FDR P¼0.069) and a 1.14% decrease in miR-101expression (FDR P¼0.088). The remaining seven miRNAs (miR-
145, miR-197, miR-30b, miR-345, miR-425–5p, miR-331, and miR-
140–3p) had decreases in expression ranging from 0.61% to 0.95%
(Table 3).
3.5. Mediated moderation analysis
We performed mediated moderation analysis to estimate the
extent to which the top nine validated miRNAs mediated the ef-
fects of PM10 exposure on BP, considering the moderator effect of
BMI. The relationship between PM10 and BMI was not signiﬁcant,
Pearson's correlation coefﬁcient was 0.011 (P¼0.920). Of the top
nine miRNAs, only miR-101 satisﬁed the underlying assumptions
for mediated moderation analysis. In the analysis, miR-101 was
negatively associated with PM10 (β21¼0.015, SE¼0.004,
P¼0.001) and with the PM10BMI interaction term
(β23¼0.003, SE¼0.001, P¼0.002) (see Supplemental ﬁle: Sup-
plemental Table 4). Subsequently, diastolic BP was predicted by
the miR-101BMI interaction (β35¼0.624, SE¼0.274, P¼0.025)
(see Supplemental ﬁle: Supplemental Table 4, Eq. (3)).
On the basis of these ﬁndings, we hypothesized that PM10 ex-
posure, in a manner moderated by BMI, leads to reduced miR-101
expression and increased diastolic BP. We estimated the CIE. Given
the overall signiﬁcant interaction term, signiﬁcance tests were
conducted to test the hypothesis that CIE¼0 at speciﬁed values
(mean71 SD) of the moderator. A bootstrapped 95% CI conﬁrmed
that the indirect effects of PM10 on diastolic BP by miR-101 were
signiﬁcant only for low values of mean BMI (Mean1 SD)
(CIE¼0.1431, 95% CI¼0.3091 to 0.0288) (Table 4 and Sup-
plemental Fig. 1). The association between systolic BP and the
interaction term (miR-101BMI) was not statistically signiﬁcant.
Moreover, the CIE was not signiﬁcant at different values of BMI
(see Supplemental ﬁle: Supplemental Table 4).
Table 4
Conditional indirect effect (CIE) of PM10 exposure on blood pressure (BP) via miR-
101 at different body mass index (BMI) levels.
Systolic BP CIE SEa 95% CIb
BMI [þ 1 SD] 0.002 0.034 0.051 0.101
Average BMI 0.005 0.036 0.069 0.071
BMI [1 SD] 0.150 0.112 0.409 0.053
Diastolic BP CIE SEa 95% CIb
BMI [þ 1 SD] 0.001 0.017 0.030 0.046
Average BMI 0.018 0.022 0.069 0.024
BMI [1 SD] 0.143 0.069 0.309 0.029
a SE: Standard error.
b 95% CI: Conﬁdence interval.
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The top nine miRNAs (miR-101, miR-140–3p, miR-145, miR-197,
miR-26a, miR-30b, miR-331, miR-345, and miR-425–5p) that were
signiﬁcantly associated with PM10 exposure levels were further
investigated, together with their target genes, by functional ana-
lysis using Ingenuity Pathway Analysis (IPA) software (see Sup-
plemental material: Prediction of miRNA Targets).
Target enrichment analysis of the nine miRNAs identiﬁed 3759
unique mRNAs that were experimentally observed or predicted
with a high conﬁdence level. Numbers of downstream regulated
mRNAs for each miRNA are shown in Supplemental ﬁle, Supple-
mental Table 5.
To investigate whether the mRNAs targeted by the nine miR-
NAs were potentially involved in biological processes connected to
BP regulation, we performed functional analyses for diseases and
functions involved in cardiovascular disorders. CVDs and functions
were selected according to their P-values and the number of mo-
lecules involved. Target genes of the nine CVD-associated miRNAs
were largely involved in artery disorders, vascular disease, hy-
pertension, and occlusion of arteries (see Supplemental ﬁle: Sup-
plemental Table 6).
As miR-101 was found to mediate the effects of PM10 exposure
on BP, we performed a Tox Lists analysis with IPA to uncover
pathways and molecular mechanisms that may be altered by
toxicant exposure to PM10. The miR-101 targets (n¼849) mapped
to ﬁve toxicological pathways, belonging to RAR activation, cardiac
hypertrophy, cardiac necrosis/cell death, increased heart failure,
and p53 signaling (see Supplemental ﬁle: Supplemental Table 7).4. Discussion
In this study of 90 overweight and obese adults in Lombardia,
Italy, we found an increase in systolic and diastolic BP levels 24
and 48 h after exposure to levels of PM10. Obese individuals were
chosen for this study due to their increased susceptibility to the
effects of air pollution (due to a higher particle accumulation rate)
(Bennett and Zeman, 2004; Bollati et al., 2014). We identiﬁed and
validated a distinct signature of nine miRNAs (miR-145, miR-197,
miR-30b, miR-345, miR-26a, miR-425–5p, miR-331, miR-140–3p,
and miR-101) in the peripheral blood, which were associated with
PM10 exposure levels 48 h after exposure. Among these nine
miRNAs, only miR-101 mediated the effects of particle exposure on
diastolic BP, possibly inﬂuencing the risk of developing CVD.
Identiﬁcation of a PM exposure time of 48 h in association with
BP is consistent with ﬁndings from previous studies focused on
cardiovascular outcomes. Dominici et al. (2006) showed a higher
risk of CVD hospitalizations across 204 United States counties 24–
48 h after exposure to PM with an aerodynamic diameter of2.5 μm or less (PM2.5), using single-day average measures . The
strongest association was found for heart failure, which had a
1.28% increased risk for each 10-μg/m3 increase in PM2.5. Zanobetti
et al. (2009) estimated the association between 2-day mean PM2.5
levels and emergency hospital admissions for CVD, MI, and con-
gestive heart failure in 26 US communities, reporting larger effect
sizes than Dominici.
We found that an increase in ambient PM10 of 1 μg/m3 was
associated with an increase in mean systolic and diastolic BP levels
of 0.67–1.24 mmHg 48 h after exposure. Consistent with our re-
sults, Kubesch et al. (2015) reported a PM10-associated increase in
systolic BP of 0.98 mmHg after 5 h of exposure. Dvonch et al.
(2009) found an average increase in systolic BP of 3.2 mmHg
2 days after exposure to urban PM2.5 .
The molecular pathways that determine the systemic changes
in blood pressure levels after PM exposures are still largely un-
known. We propose that inhaled air particles provoke alveolar
inﬂammation which causes the release of mediators such as
miRNAs, able to modulate systemic inﬂammation and related
health effects. Alveolar macrophages and pulmonary epithelial
cells constitute the ﬁrst line of defense against inhaled noxious
compounds. They have been suggested to initiate a cascade of pro-
inﬂammatory cytokines (TNF, IL-1, IL-6, and GM-CSF), upon PM
exposure, that can rapidly extend to systemic circulation (Van
Eeden et al., 2001; Wang et al., 2005). These systemic reactions can
be assessed through expression analysis, in circulating leukocytes,
of miRNAs related to inﬂammatory pathways and oxidative stress,
which are exquisitely sensitive to PM exposure (Jardim et al.,
2009). Recent data from healthy human subjects suggest that
circulating miRNAs may be an active component of the cellular
response to PM exposure. Vrijens et al. demonstrated that miR-10b
and miR-128 are distinct miRNAs that are frequently over-
expressed after exposure to air pollution in in-vitro and human
studies (Vrijens et al., 2015). Our group previously published re-
sults on a population of foundry workers who were highly ex-
posed to metal-rich PM. We identiﬁed four differentially expressed
inﬂammatory miRNAs after short-term exposure to PM10 for
4 days (Motta et al., 2013). In a population of elderly males, an
association was discovered between PM2.5 and expression levels of
eight miRNAs involved in the immune response after exposure to
PM2.5 for 4 h to 28 days (Fossati et al., 2014).
The present study reports the results of regression models as
the percent change in miRNA expression for each 1-μg/m3 in-
crease in PM10 exposure level. Small percent changes were found
for the nine identiﬁed miRNAs, indicating tight regulation of the
miRNA expression mechanism. Bioinformatics analysis with IPA
further showed that these nine miRNAs are largely involved in
artery disorders/occlusion, vascular diseases, and hypertension.
Among the nine miRNAs identiﬁed in this study, the literature
provides distinct and well-established roles for miR-145, miR-30b,
and miR-26a in CVD. MiR-145 plays a role in vascular smooth
muscle cell development and function. Altered expression of this
miRNA has been linked to pathological changes in the vasculature,
such as vascular remodeling, aortic aneurysm, and atherosclerosis
(Hata, 2013). MiR-145–null mice exhibit blood vessels with re-
ductions in the medial layer thickness, vascular tone, and BP,
suggesting that miR-145 is required for normal contractility of the
arteries and normal BP (Boettger et al., 2009). The miR-30 family,
including miR-30b, is encoded by six genes that are abundantly
expressed in the heart under physiological conditions. Involve-
ment of the miR-30 family in cardiovascular pathophysiology has
only emerged recently. Using a well-established rat model of AMI
to investigate the role of aberrantly expressed miRNAs in different
areas of infarcted rat hearts, Dong et al. (2009) observed that miR-
30b expression was upregulated in the noninfarcted areas, sug-
gesting an important role in the pathophysiology of ischemic heart
V. Motta et al. / Environmental Research 146 (2016) 274–281280disease. MiR-26a is involved in vascular remodeling. Studies using
experimental mouse models identiﬁed increased miR-26a levels in
association with reduced phosphatase and tensin homolog (PTEN)
expression (a target of miR-26a), as well as activation of the signal
transduction Akt-pathway, resulting in altered myogenic tone and
growth of the vessel wall (Bhattachariya et al., 2014).
The results of our mediated moderation analysis are consistent
with the hypothesis that, among the nine studied miRNAs, only
miR-101 mediates the effects of particle exposure on diastolic BP.
Based on the a priori assumption that a mediated effect is biolo-
gically plausible, this approach decomposes the total observed
effect of exposure on BP into direct and indirect effects, with the
latter acting via miR-101. We found that miR-101 mediates the
indirect effect of PM10 on diastolic BP, and that this effect is sig-
niﬁcant only in patients with lower values of mean BMI. These
results indicate possible beneﬁcial roles of miR-101 in counter-
acting the acute adverse effects of PM10 on diastolic BP, but only in
subjects with higher BMI mean levels.
These ﬁndings might open up two different scenarios. The ﬁrst
scenario indicates obesity (BMI) as modiﬁer of the association
between ambient air pollution exposure and blood pressure. A
clinical controlled study conducted on 348 participants ages Z25
years in the United States showed that exposure to PM2.5 at lags
2 and 3 was associated with an increased risk for elevated pulse
pressure among those who were determined to be obese accord-
ing to their BMI. Results from this study suggest that obesity may
be a modiﬁer of the association between ambient air pollution
exposure and blood pressure (Kannan et al., 2010). Therefore, we
hypothesize that obesity would modify the association between
air pollution exposure and blood pressure, with a stronger asso-
ciation in obese subjects with higher BMI than in individuals of
lower BMI.
The second scenario suggests that the clinical conditions re-
lated to obesity might somehow interfere with the role of miRNA-
101. Adipose tissue produces high serum concentrations of various
pro-inﬂammatory cytokines, chemokines and adipokines, con-
tributing to endothelial dysfunction, renin–angiotensin system
activation, sympathetic activation, and oxidative stress (Sood,
2010). The pro-inﬂammatory state can be also associated to the
failure of anti-inﬂammatory mechanisms such as miR-101 that is
involved in the regulation of endothelial function and athero-
sclerosis. Pan et al. identiﬁed miR-101 as a cardiac ﬁbrosis-related
miRNA. In postinfarct rats, miR-101 overexpression mitigated in-
terstitial ﬁbrosis and the deterioration of cardiac performance,
indicating the therapeutic potential of miR-101 for ﬁbrosis-asso-
ciated cardiac disease (Pan et al., 2012). The complex inﬂammatory
state associated to obesity may be the reason why the mediating
beneﬁcial role of miR-101 on the relationship between air pollu-
tion exposure and blood pressure differs in individuals with dif-
ferent classes of obesity. However, we did not ﬁnd any direct
evidence in this study.
Growing evidence suggests that the evaluation of miRNA ex-
pression levels in the peripheral blood of healthy individuals may
be a useful tool in elucidating the mechanisms leading to changes
in BP and in predicting human CVD. Blood RNA is derived from a
mixed cell population containing different types of circulating
white blood cells. Although exposure to PM10 had no signiﬁcant
effects on the proportions of the major leukocyte cell types, the
models were adjusted for the proportion of granulocytes.
Our study aimed at investigating the entire population of a
region, rather than selected locations near monitoring sites, as was
commonly done in previous studies. By selecting PM10 as the ex-
posure value, we aimed to detect the effects of different sources
and components of PM that might trigger cardiovascular out-
comes. The average daily PM10 exposure concentration in the
study period was 36.4 mg/m3. This value is higher than the WHOAir Quality Guideline (AQG) of 20 μg/m3, but considerably lower
than previously reported occupational (Bonzini et al., 2010) and
chamber studies, (Gamble and Lewis, 1996) in which levels ex-
ceeded hundreds of micrograms per cubic meter. Our ﬁndings
suggest that even levels close to the WHO AQG limits can lead to
effects on BP and can have major effects on miRNA expression
levels.
The strength of this study was the use of a nontargeted, ex-
ploratory approach to select candidate miRNAs. We chose to use a
real-time PCR approach for miRNA expression analysis because of
the high precision and sensitivity required to detect closely related
miRNAs, which might differ in sequence by only one base (Mackay
et al., 2002). Also, to limit false positives in the detection of dif-
ferentially-expressed miRNAs, we used restrictive statistical sig-
niﬁcance cut-offs. In addition, the personal levels of exposure to
PM10, assessed by the FARM Eulerian grid model, provided us with
a unique method to efﬁciently study PM effects in humans.
However, our study has some limitations. First, from the initial
list of 122 miRNAs, we chose to validate a group of 28 miRNAs.
Although we used different selection criteria based on statistical
signiﬁcance, biological role and consideration of our preliminary
data on the whole SPHERE population, it remains possible that we
may have excluded some relevant miRNAs involved in PM10 ex-
posure and BP regulation. In our analysis, we adjusted for potential
confounding variables. We did not include in our models clinical
variables such as diabetes, cholesterol levels, physical activity, al-
cohol consumptions and medications. Even though individual
factors that may affect PM exposure estimation (such as in-
formation on residence area and ﬂoor of residence) have been
collected in a questionnaire, we chose not to use these variables
because of the small sample size. Moreover, the relatively small
sample size might have limited our ability to detect signiﬁcant
effects, and larger studies are needed to conﬁrm our ﬁndings.5. Conclusions
The mediated moderation analysis we performed allowed us to
conclude that the air pollution effect on BP is likely to be regulated
by a change in miRNA expression levels in blood. Future studies
could build upon the approach presented here to investigate si-
milar events in other tissues or in diverse exposure conditions.
Additionally, we performed a target analysis with the aim of
providing a list of possible genes and pathways to be further in-
vestigated with in-vitro and animal models. It would be necessary
to experimentally test our results in order to provide a mechanistic
role for miR-101.Funding sources
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